首页 百科知识 肝硬化结节癌变的影像学监测

肝硬化结节癌变的影像学监测

时间:2023-07-05 百科知识 版权反馈
【摘要】:肝硬化时肝纤维化不断进展,进一步发展形成结节。25%~49%的肝硬化患者可以合并肝癌。肝实质正常血供的75%来自门静脉;肝硬化的良性结节以门静脉的血供为主,随着结节恶性程度的增高,由于肿瘤新生血管的生长,结节内部门静脉的供血比例逐渐减少,而肝动脉的供血比例逐渐增多。CT和(或)MRI能鉴别大部分的肝硬化结节的性质,个别影像表现不典型者,需要随诊复查或穿刺活检。

肝硬化时肝纤维化不断进展,进一步发展形成结节。25%~49%的肝硬化患者可以合并肝癌。肝硬化结节癌变是一个连续的、多阶段的病理过程,按照良性再生结节(regenerative nodule,RN)、退变结节(dysplastic nodule,DN)、小肝细胞癌(small hepatocellular carcinoma,SHCC)逐渐演变。

RN是被硬化肝粗糙纤维包绕的局灶增生的肝实质小岛,结节致密,内含正常的肝细胞、Kupffer细胞及小胆管等结构,直径多为3~10mm。DN也曾被称为腺瘤样增生、不典型增生结节、异型增生结节等。DN无真正包膜,直径通常>10mm,少数可>20mm。DN可含有不成对血管以及胆管。DN中细胞核占细胞的比例增加,因而结节密度相对略高于周围的肝组织,而且随着假腺体形成,肝实质细胞脂肪变等,结节的MR信号可发生改变。DN可分为低级别(low grade DN,LGDN)和高级别(high grade DN,HGDN)两类。其中HGDN的细胞异型性较明显,不成对的血管数目更多,被认为是一种癌前病变。当DN内部出现癌灶(结节中结节)时结节就转化为肝癌。一般将直径<20mm的肝细胞癌称为小肝细胞癌(SHCC)。

肝实质正常血供的75%来自门静脉;肝硬化的良性结节以门静脉的血供为主,随着结节恶性程度的增高,由于肿瘤新生血管的生长,结节内部门静脉的供血比例逐渐减少,而肝动脉的供血比例逐渐增多。有研究表明,96%的DN主要由门静脉供血,而90%的SHCC结节则主要由肝动脉供血。SHCC瘤内血供还与瘤体分化程度有关,门脉供血多者,癌细胞分化较好;门脉血供少者,癌细胞分化较差。尽管HGDN与分化较好的SHCC之间的肝动脉、门静脉供血比例有一定的重叠、没有截然界限,但是因为两者演变关系极为密切,一旦发现,都应该尽早处理。

影像学检查对于肝硬化结节的监测非常有价值。

CT平扫肝内RN多呈等密度,DN多呈高密度,SHCC多呈稍低密度,但由于CT平扫时病灶与周围肝实质的密度差异较小,小结节病变常易漏诊或误诊。MRI无放射损害,且分辨力、敏感性和特异性均较高,一方面能够通过信号特征来分析结节的组织成分,判断结节是否恶变;另一方面还可以通过揭示结节的供血来源帮助诊断早期小肝癌结节。当B超、CT或两者均难以判定结节良恶性时,MRI可作为主要诊断技术。既往研究显示,在MRI T1WI,RN多呈等、稍高信号,有时也可呈稍低信号;典型DN呈高信号;SHCC一般可呈稍低、等、稍高信号,与前两者有一定程度的重叠。在MRI T2WI,RN常呈等、稍高信号;DN呈等、低信号;SHCC呈高信号。一般认为,在MRI T2WI 结节呈低信号是DN区别于SHCC 的一个重要特征,如果结节内出现高信号应高度怀疑结节已恶变。

RN、LGDN的血供大多数与邻近肝实质相仿,增强扫描时RN、LGDN仍与正常肝组织同时强化,而HGDN与SHCC于CT扫描动脉期结节明显增强,门脉期又恢复其低密度或因双重血供而呈等密度,延迟期为低密度。尽管CT不能完全区分开HGDN和SHCC,但无论如何,CT增强扫描动脉期结节明显强化的征象提示了结节从门静脉供血向肝动脉供血的转变而产生的变化,反映了肿瘤血管的生成,有利于确认病灶的恶变倾向。有资料表明,动脉期强化的DN可以在4个月至2年演化为SHCC,因此在肝硬化结节的随访过程中,如果CT增强扫描动脉期出现血供,都要提示临床需积极处理,通过早期手术或介入治疗来提高患者的预后(图1-212至图1-215)。

图1-212 肝退变结节

A.CT平扫轴位图,示肝实质内大小不一的高密度结节(细箭),肝裂处呈稍低密度影(粗箭);B.CT增强扫描动脉期,结节(细箭)与周围肝实质同步强化,仍呈高密度影,提示结节与周围肝实质的动脉血供一致;肝裂处可见条纹状强化(粗箭),为开放的曲张静脉;C.CT增强扫描门脉期,大部分结节与周围肝实质比较呈等密度,提示结节门静脉的供血比例逐渐减少,为LGDN;肝Ⅷ段结节(细箭)仍呈高密度影,提示结节双重血供大致如常,为RN→LGDN;肝裂处曲张静脉强化更加明显(粗箭);胃底静脉曲张呈结节状,凸向管腔,局部胃底黏膜层萎 缩;D.CT增强扫描门脉期冠状位重组图,肝内大部分结节呈等密度,提示该患者肝实质内大部分结节门静脉供血稍减少

图1-213 肝低级别退变结节

A.CT平扫轴位图,示肝Ⅷ段外凸结节(无尾箭头),较周围肝实质密度稍高;B.CT增强扫描动脉期,肝Ⅷ段结节与周围肝实质同步强化,提示结节肝动脉血供尚未明显增多;C.CT增强扫描门脉期,结节内部密度轻微减低,提示门静脉供血减少;D.CT增强扫描门脉期冠状位重组图,较B图容易观察到结节内部密度轻微减低。病理诊断该结节:肝细胞变小,肝板稍增厚,结节内未见门管区

图1-214 肝低级别退变结节

乙肝病史多年,A.MRI T1WI轴位抑脂图像,示肝信号略不均匀,其中Ⅷ段可见一高信号结节;B.MRI T2WI轴位,示肝内多发低信号结节,Ⅷ段T1WI高信号结节亦呈低信号改变;C.MRI T1WI增强扫描动脉期抑脂图像,示肝内结节与周围肝实质同步强化,呈等信号;D.MRI T1WI增强扫描门脉期抑脂图像,示肝内结节与周围肝实质仍呈同步强化,呈等信号

图1-215 肝高级别退变结节或小肝癌

A.CT平扫轴位图,示肝表面凹凸不平,肝周积液,肝实质内密度尚均匀;B.CT增强扫描动脉期,示肝Ⅳ段多个明显强化结节,提示结节动脉血供增加;C.CT增强扫描门脉期,示肝实质均一强化,动脉期强化结节呈等密度

以下征象高度提示DN癌变:①T2WI上呈略低信号的结节复查时已转呈略高信号;②病灶在CT扫描或T2WI上表现为“结节中结节”(图1-216);③动脉期结节明显强化;④病灶逐渐增大;⑤病灶摄取肝细胞或Kupffer细胞特异性对比剂的能力降低。CT和(或)MRI能鉴别大部分的肝硬化结节的性质,个别影像表现不典型者,需要随诊复查或穿刺活检。

图1-216 小肝癌

A.CT平扫轴位图。肝Ⅷ段可见一等低密度混杂结节,结节以低密度为主,其后下部可见不规则软组织密度实性结节(无尾箭头);B.CT增强扫描动脉期,示结节中结节明显中度强化(无尾箭头),其余部分无强化;C.CT增强扫描门脉期,示结节中结节强化消退(无尾箭头),与周围肝实质比较呈稍低密度;D.CT增强扫描门脉期薄层,消除了由于层厚所造成的部分容积效应,结节中结节显示更加清楚(无尾箭头);病理示肝细胞癌并凝固性坏死

另外,肿瘤血管和肿瘤染色是小肝细胞癌的DSA肝动脉造影诊断的主要征象。但如果肿瘤血管不明确,只要有确切的肿瘤染色,便可诊断小肝细胞癌。鉴别困难时亦可行碘油造影CT检查。碘油能选择性沉积于肝癌瘤体内,进入非癌肝组织内的碘油明显少于肝癌瘤体;而且3周后正常肝组织内网状内皮细胞可吞噬廓清所沉积的碘油,RN或LGDN结节也不能长期聚积碘油,HGDN和多血供的SHCC组织内由于无网状内皮细胞,碘油将长期存留。因此,肝动脉碘油造影3~4周进行CT扫描也能有效发现HGDN或SHCC病灶。有研究对比US、CT、MRI、DSA和肝动脉碘油造影CT,发现肝动脉碘油造影CT对于SHCC特别是<10mm的SHCC最为敏感(图1-217,图1-218),容易确定病变性质。

图1-217 常规CT扫描

A.CT平扫示肝表面凹凸不平,肝周可见积液,肝实质内未见异常密度影;B.CT增强扫描动脉期,肝实质内未见异常强化;C.CT增强扫描门脉期,肝实质内仍未见明确病灶,但临床实验室检查AFP明显增高

图1-218 经肝动脉注射碘油

与图1-217为同一病例。A.选择性插管,经肝动脉注射碘油,可见肝区斑片状碘油沉积;B.肝动脉碘油造影后1个月复查CT,示肝实质内点片状碘油沉积;C.肝动脉碘油造影后2个月复查CT,示肝实质内大部分沉积碘油已廓清,部分碘油沉积区呈结节状;D.肝动脉碘油造影后3个月复查,CT平扫示正常肝实质内沉积碘油基本廓清,其余肝实质内碘油潴留呈结节状者为HGDN或SHCC;E.CT增强扫描动脉期,结节内碘油沉积较完全,未见明确强化;F.CT增强扫描门脉期,肝实质内未见其他异常强化结节

(郑可国 范 淼 杨 栋)

参考文献

[1]C.S. van Kessel,M.S. van Leeuwen,M.A.A.J. van den Bosch,el al.Accuracy of multislice liver CTand MRI for preoperative assessment of colorectal liver metastases after neoadjuvant chemotherapy.Dig Surg,2011,28:36-43.

[2]R. Adam.Chemotherapy and surgery:new perspectives on the treatment of unresectable liver metastases.Annals of Oncology,2003,14:13-16.

[3]Young-sun Kim,Hyunchul Rhim,Hyo K. Lim,et al.Completeness of treatment in hepatocellular carcinomas treated with image-guided tumor therapies:evaluation of positive predictive value of contrast-enhanced CTwith histopathologic correlation in the explanted liver specimen.J Comput Assist Tomogr,2006,30:578-582.

[4]Hyo Soon Lim,Yong Yeon Jeong,Heoung Keun Kang,et al.Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation.AJR,2006,187:341-349.

[5]Wolfgang Schima,Ahmed Ba-Ssalamah,Amir Kurtaran,et al.Post-treatment imaging of liver tumours.Cancer Imaging,2007,7:28-36.

[6]Bert H. O’Neil,Alanp. Venook.Hepatocellular carcinoma:the role of the north american GI steering committee hepatobiliary task force and the advent of effective drug therapy.The Oncologist,2007,12:1425-1432.

[7]龚高全,王小林,王建华,等.乏血供肝脏肿瘤经肝动脉化疗栓塞后胆汁瘤形成(附11例报道).复旦学报(医学版),2008,35:597-608.

[8]D.J. Doyle,A.E. Hanbidge,M.E. O’Malley.Imaging of hepatic infections.Clinical Radiology,2006,61:737-748.

[9]Koenraad J. Mortele,Enrica Segatto,Pablo R. Ros.The infected liver:radiologic-pathologic correlation.RadioGraphics,2004,24:937-955.

[10]牛秀峰,倪家连.肝脓肿的外科治疗进展.临床外科杂志,2006,14:30-31.

[11]王刚,孙备,许军,等.肝脓肿的综合治疗(附32例报告).临床外科杂志,2005,13:325-326.

[12]Woong Yoon,Yong Yeon Jeong,Jae Kyu Kim,et al.CTin blunt Liver traumA.RadioGraphics,2005,25:87-104.

[13]Andreas Christe,Steffen Ross,Lars Oesterhelweg,et al.Abdominal trauma-sensitivity and specificity of postmortem noncontrast imaging findings compared with autopsy findings.J Trauma,2009,66:1302-1307.

[14]Luigia Romano,Sabrina Giovine,Guido Guidi,et al.Hepatic trauma:CTfindings and considerations based on our experience in emergency diagnostic imaging.European Journal of Radiology,2004,50:59-66.

[15]吴健卫.临床肝脏移植.上海:第二军医大学出版社,1997.

[16]黄洁夫.肝脏移植的理论与实践.广东:广东科技出版社,1998.

[17]周得路.原位肝移植术后胆道并发症.国外医学,1999,20:76-78.

[18]石景森,王炳煌.外科黄疸疾病诊断治疗学.北京:人民军医出版社,2003.

[19]范淼,李子平,周旭辉,等.肝移植术后胆系并发症的T管造影表现.临床放射学杂志,2004,23:584-588.

[20]范淼,李子平,孟悛非,等.肝移植术后胆系并发症的影像学表现与病理对照.中华放射学杂志,2006,40:61-64.

[21]范淼,李子平,王晓燕,等.多层螺旋CT血管造影在肝移植术后血管源性并发症中的应用.广东医学,2006,27:620-622.

[22]彭谦,范淼,张彩霞.活体肝移植术前供肝体积的CT测量方法比较及应用.中华普通外科文献,2008,2:32-34.

[23]夏穗生.临床肝移植进展中的思考.中华肝胆外科杂志,2005,11:721-724.

[24]叶晟.成人“两供一受”肝移植的进展.外科理论与实践,2004,9:531-532.

[25]沈文,尹建忠,陈光,等.肝移植术后影像学表现.临床放射学杂志,2004,23:396-400.

[26]谈景旺,江艺,姚和祥,等.肝移植术后胆道并发症的防治.中华器官移植杂志,2002,23:98-100.

[27]陈光,沈文,陈凯,等.MSCT血管成像与血管造影对肝移植术后肝动脉狭窄观察对比研究.放射学实践,2003,18:5-7.

[28]陈知水,叶启发,曾凡军,等.肝移植术后胆泥及胆结石形成原因分析.中华器官移植杂志,2001,22:143-144.

[29]靳二虎,马大庆.肝移植前后的影像检查.中国医学影像技术,2000,16:157-158.

[30]Rull R,Garcia Valdecasas JC,Grande L,et al.Intrahepatic biliary lesions after orthotopic liver transplantation.Transpl Int,2001,14: 129-134.

[31]Langnas AN,Marujo W,Stratta RJ,et al.Vascular complications after orthotopic liver transplantation.AmJ Surg,1991,161:76-82.

[32]Orons PD,Zajko AB,Bron KM,et al.Hepatic artery angioplasty after liver transplantation:experience in 21 allografts. J Vascul Intervent. Radiology,1995,6(4):523-529.

[33]Valente JF,Alonso MH,Weber FL,et al.Late hepatic artery thrombosis in liver allograft recipients is associated with intrahepatic biliary necrosis.Transplantation,1996,61:61-65.

[34]Settmacher U,Stange B,Haase R,et al.Arterial complications after liver transplantation.Transpl Int,2000,13:372-378.

[35]Ramon R,Juan CG,Luis Grande,et al.Intrahepatic biliary lesions after orthotopic liver transplantation.Transpl Int,2001,14:129-134.

[36]Meersschaut V,Mortele KJ,Troisi R,et al.Value of MR cholangiography in the evaluation of postoperative biliary complications following orthotopic liver transplantation.Eur radiol,2000,10:1576-1581.

[37]Piero B,Giovanni B,Roberto G,et al.Detection of biliary complications after orthotopic liver transplantation with MR cholangiography.Magnetic Resonance Imaging,2001,19:1097-1105.

[38]Shuhart MC,Kowaley KV,Mcvicar JP,et al.Predictors of bile leaks after T tube removal in orthotopic liver transplant recipients.Liver Transpl-surg,1998,4:62-70.

[39]Nosaka T,Bowers JL,Cay O,et al.Biliary complications after orthotopic liver transplatation in Rats.Jpn J Surg,1999,29:963-965.

[40]Fulcher AS,Turner MA,Franklin KJ,et al.Primary sclerosing cholangitis:evaluation with MR cholangiography:a case control study.Radiology,2000,215:71-80.

[41]Inomata Y,Tanaka K.Pathogenesis and treatment of bile duCTloss after liver transplantation.J Hepatobiliary Pancreat Surg,2001,8:316-322.

[42]Right D,Cesarani F,Muraro E,et al.Role of interventional radiology in the treatment of biliary strictures following orthotopic liver transplantation.Cardiovasc Intervent Radiol,2002,25:30-35.

[43]Staffordjohnson DB,Hamilton B,Dong Q,et al.Vascular complications of liver transplantation:evaluation with gadolinium enhanced MR angiography.Radiology,1998,201:153-160.

[44]Quiroga S,Sebastia MC,Margarit C,et al.Complications of orthotopic liver transplantation:spectrum of findings with helical CT.Radiographics,2001,21:1085-1102.

[45]Kamel IR,Kruskal JB,Pomfret EA,et al.ImpaCTof multidetector CTon doner selection and surgical planning before living adult right lobe liver transplantaton.AJR,2001,176:193-200.

[46]Ishifuro M,Horiguchi J,Nakashige A,et al.Use of multidutector row CTwith volume renderings in right lobe living liver transplantation.Eur Radiol,2002,12:2477-2483.

[47]Cheng YF,Chen YS,Huang TL,et al.Interventional radiologic procedures in liver transplantation.Transpl Int,2001,14:223-229.

[48]Prokesch Rupert W,Schima W,Berlakovich G,et al.Adrenal hemorrhage after othotopic liver transplantation:MR appearance.Eur Radiol,2001,11:2484-2487.

[49]Nalesnik MA.Posttansplantation lymphoproliferative disorder (PTLD):current perspective.Semin Thorac Cardiovasc Surg,1996,8:139-148.

[50]Pickhardt PJ,Siegel JM.Posttransplantation lymphoproliferative disorder of the abdomen:CTevaluation in 51 patients.Radiology,1999,213:73-78.

[51]Bogetti JD,Herts BR,Sands MJ,et al.Accuracy and utility of three dimensional computed tomography in evaluating donors for adult living related liver transplants.Liver Transpl,2001,7:687-692.

[52]Nolten A,Sproat IA.Hepatic artery thrombosis after liver transplantation:temporal accuracy of diagnosis with duplex US and the syndrome of impending thrombosis.Radiology,1996,198:553-559.

[53]Platt JF,Yutzy GG,Bude RO,et al.Use of doppler sonography for revealing hepatic artery stenosis in liver transplant recipients.AJR,1997,168:473-476.

[54]李果珍.临床CT诊断学.北京:人民出版社,1994.

[55]周康荣.腹部CT.上海:上海医科大学出版社,1993.

[56]周康荣.螺旋CT诊断学.上海:上海医科大学出版社,1998.

[57]石木兰.肿瘤影像学.北京:科学出版社,1999.

[58]黄洁夫.腹部外科学.北京:人民卫生出版社,2001.

[59]李松年.现代全身CT诊断学.北京:中国医药科技出版社,2001.

[60]黄志强,林言箴,祝学光,等.腹部外科学理论与实践.北京:科学出版社,2003.

[61]武正炎.普通外科手术并发症预防与处理.北京:人民军医出版社,2007.

[62]姜晓静,石艳玲,李振明.肝硬化退变结节及小肝细胞癌的CT诊断(附20例报告).实用医学影像杂志,2008,9:157-159.

[63]许达生.小肝癌的血供与螺旋计算机X线体层扫描诊断.中华肝脏病杂志,2003,11:564.

[64]王建华,周康荣,颜志平,等.小肝癌的介入治疗研究(附42例报告).中华放射学杂志,2000,34:824-825.

[65]Park YN,Yang CP,Fernandez GJ,et al.Neoangiogenesis and sinusoidal“capillarization” in dysplastic nodules of the liver.Am J Surg Path,1998,22:656-662.

[66]Inada M,Kita K,Kondo F,et al.Large regenerative nodule perfused by the portal vein.J Gastroenterol Hepatol,2005,20:1794-1798.

[67]Hussain SM,Zondervan PE,IJzermans JN,et al.Benign versus malignant hepatic nodules:MR imaging findings with pathologic correlation.Radiographics,2002,22:1023-1036.

免责声明:以上内容源自网络,版权归原作者所有,如有侵犯您的原创版权请告知,我们将尽快删除相关内容。

我要反馈